Patient Buzz: The Staph-Itch Connection | The Expert Weighs In
HealthCentral recently highlighted new research out of Harvard Medical School on the role of Staphylococcus aureus (S. aureus) in itch. Researchers found S. aureus can trigger itch in mice and human cells through communication with sensory neurons.
For an expert’s take, I reached out to Gil Yosipovitch, MD, professor, Stiefel Chair of Medical Dermatology and director of the Miami Itch Center …
HealthCentral recently highlighted new research out of Harvard Medical School on the role of Staphylococcus aureus (S. aureus) in itch. Researchers found S. aureus can trigger itch in mice and human cells through communication with sensory neurons.
For an expert’s take, I reached out to Gil Yosipovitch, MD, professor, Stiefel Chair of Medical Dermatology and director of the Miami Itch Center … Continue reading "Patient Buzz: The Staph-Itch Connection | The Expert Weighs In"
Metronidazole is a nitroimidazole with antiprotozoal, antibacterial, and anti-inflammatory properties and is available in oral and topical formulations. The diverse mechanisms of action of metronidazole have expanded its utility across various dermatologic conditions. Topical metronidazole is well tolerated and has demonstrated improvements in inflammatory papules and pustules of rosacea. We conti … 
Cemiplimab is a monoclonal antibody therapy that has emerged as a promising treatment option for certain types of advanced skin cancer. Specifically designed to target the programmed cell death protein 1 (PD-1) pathway, cemiplimab works by blocking the interaction between PD-1 and its ligands, PD-L1 and PD-L2, thereby unleashing the body's immune system to recognize and attack cancer cells. We con … 
Basal cell carcinoma (BCC) is the most common human cancer. When curative surgery and radiotherapy are contraindicated, systemic agents targeting the hedgehog signaling pathway are invaluable options for this subset of adult patients with locally advanced BCC (laBCC). Vismodegib and sonidegib are oral options with similar efficacy and side effect profiles. With the absence of head-to-head comparis … 
Ciclopirox is the only hydroxypyridone antifungal agent with a unique mechanism of action differentiating it from other antimycotic agents. Unlike the azole-antifungals which block the sterol synthesis in the fungal cell membrane, ciclopirox functions by chelating cations resulting in the degradation of fungal cells, as well as proposed anti-inflammatory properties. It is available in a variety of … 